BIT Biotech Opportunities S
WKN A3DCA9 | ISIN DE000A3DCA95 | Fonds
Fonds
| ISIN | Name | Performance | Volatilität | Sharpe Ratio | ||
|---|---|---|---|---|---|---|
| 1 | LU1540961759 | HBM UCITS (LUX) FUNDS - HBM Global Biotechnology Fund A Cap USD | -3,44 % | +18,79 % | -0,30 |
|
| 2 | LU2026682919 | Candriam Equities L Biotechnology, V2 - Capitalisation | -4,07 % | +20,43 % | -0,31 |
|
| 3 | LU1540962054 | HBM UCITS (LUX) FUNDS - HBM Global Biotechnology Fund P Cap USD | -3,94 % | +19,62 % | -0,32 |
|
| 4 | LU0942225912 | Candriam Equities L Biotechnology, R - Capitalisation | -4,29 % | +20,41 % | -0,32 |
|
| 5 | LU0317020203 | Candriam Equities L Biotechnology, V - Capitalisation | -4,30 % | +20,27 % | -0,32 |
|
| 79 | LU0767968745 | Bellevue Funds (Lux) - Bellevue Obesity Solutions I GBP - Accumulating | -10,57 % | +11,98 % | -1,07 |
|
| 80 | LU0415392835 | Bellevue Funds (Lux) - Bellevue Obesity Solutions I CHF - Accumulating | -14,91 % | +13,79 % | -1,24 |
|
| 81 | DE000A3DCA95 | BIT Biotech Opportunities S | -37,43 % | +31,05 % | -1,28 |
|
| 82 | DE000A3DCBA0 | BIT Biotech Opportunities I-II | -37,50 % | +31,03 % | -1,28 |
|
| 83 | LU0415392595 | Bellevue Funds (Lux) - Bellevue Obesity Solutions B CHF - Accumulating | -15,51 % | +13,79 % | -1,29 |
|